搜索结果

疾病ID:TCMBANKDI018203

疾病名:Sinusitis

MeSH_Name:Infections; Respiratory Tract Diseases; Otorhinolaryngologic Diseases

HPO_Name:Abnormality of the immune system; Abnormality of head or neck; Abnormality of the skeletal system

UMLS_Name:Disease or Syndrome

DO_Name:disease of anatomical entity

疾病类型:disease

DisGeNET_Link:C0037199

MeSH_Link:C01; C08; C09

HPO_Link:HP:0002715; HP:0000152; HP:0000924

UMLS_Link:T047

DO_Link:DOID:7

HERB_ID:-

   疾病对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族
   疾病对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN058205 trans-resveratrol (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; SRT501; AX8004672; DB02709; RP17549; NCGC00017352-05; NCGC00017352-13; NCGC00017352-19; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 4CN-0696; I06-0437; 3,4',5-Trihydroxy-trans-stilbene; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; s1396; HMS1990H15; SAM001246888; CPD000058206; CU-01000001503-3; BPBio1_000479; NCGC00024003-14; (E)-5-(p-Hydroxystyryl)resorcinol; FT-0082623; Tox21_501111; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 01R360; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Tox21_303376; MLS001055357; NCGC00024003-13; GP5884; A827984; resveratrol; NCGC00017352-09; NCGC00017352-15; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; NCGC00024003-11; D0U3EP; ACN-034773; ST057251; EU-0101111; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; HY-16561; N1848; ACT09778; NCGC00017352-17; BRD-K80738081-001-09-6; KUC104385N; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; STL; MLS001424228; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; HMS1569F17; Resveratrol, Vetec(TM) reagent grade, 98%; HMS1921N04; IDI1_002152; Resvida; KB-02515; SR-01000000163-10; NCGC00017352-08; AB00052942_31; 3,5,4'-Trihydroxystilbene; trans-Stilbene-3,4',5-triol; Tox21_110257; NCGC00024003-12; trans-3,4′,5-Trihydroxystilbene; trans-3,4',5 - trihydroxystilbene; ZB000650; ZINC6787; DSSTox_RID_78898; NCGC00024003-09; 3fts; BB_NC-2570; SRT-501; ZX-AS004941; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; BRD-K80738081-001-23-7; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; NSC327430; LS-2146; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; NCGC00024003-04; DSSTox_CID_11980; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Prestwick3_000508; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; Resveratrol, European Pharmacopoeia (EP) Reference Standard; NCGC00015894-02; ARONIS24568; STL146386; R 5010; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; AC1L9HIC; BSPBio_003461; REGID_for_CID_445154; C14H12O3; SR-01000000163-11; 501-36-0; C03582; SRT 501; NSC 327430; NSC-327430; Spectrum5_000552; AS-12413; Trans-3,4′ NCGC00024003-06; AKOS005720936; BG01529320; BBC/741; HMS1792H15; NCGC00258925-01; TL8003323; AB00052942-29; SR-01000000163-4; SR-01000000163-16; BSPBio_000435; Opera_ID_586; NC00349; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; ZX-AT013797; 375823-41-9; HMS3403H15; 3,4',5-Trihydroxystilbene; HMS2232A18; KSC-10-164; AN-865; LMPK13090005; AJ-08292; OR46018; R0071; CHEMBL165; BRD-K25591257-001-01-2; Resveratrol, E-; BBL028252; NCGC00024003-05; LP01111; UNII-Q369O8926L; CCG-38874; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MFCD00133799; 2l98; BDBM23926; SGCUT00007; GP2549; Resveratrol, trans-; CC-34242; ST2408097; MLS001076538; AK-39118; HMS1362H15; NCGC00024003-07; ABP000376; SBB055452; NCGC00017352-16; trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Tox21_110257_1; BRD-K80738081-001-06-2; Resveratrol, certified reference material, TraceCERT(R); 3,4',5-Stilbenetriol; MCULE-5678456463; J10118; BSPBio_001114; HMS2052I09; Resveratrol, >=99% (HPLC); CS-1050; SCHEMBL19425; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; Resveratol; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; HMS3263O04; 4jaz; AB0006623; CAS-501-36-0; CCRIS 8952; MLS000069735; trans-3,4',5-trihydroxystilbene; 4qer; Tox21_201374; to_000079; SPECTRUM1502223; BC202036; API0000480; NCGC00017352-10; CHEBI:27881; NCGC00017352-24; SY014849; 3,4',5-trihydroxy-stilbene; NCGC00017352-06; PREVENTION 8 (RESVERATROL); MolPort-002-499-801; (E)-resveratrol; BCPP000091; Prestwick_619; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; SMR000058206; cid_445154; Q369O8926L; Resveratrol, analytical standard; DSSTox_GSID_31980; NCGC00017352-11; AC-727; HMS2096F17; BS0159; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; BRD-K80738081-001-10-4; NCGC00017352-12; MLS002222231; Resveratrol, natural; Lopac0_001111; BR-39118; CJ-00111; NCGC00017352-07; DTXSID4031980; CR-003; Stilbene, 2f; NCGC00017352-18; NCGC00024003-10; SC-11924; SR-01000000163-3; MLS002207121; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; NCGC00024003-00; HMS3649A20; KS-5047; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; NCGC00017352-14; HSDB 7571; NCGC00024003-08; 533C1DA0-4104-42B5-9D32-9265F40857E4; RM-1812; REGID_for_CID_6240; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; BIK9013; NCGC00257465-01; GTPL8741; BG00606847; NCGC00261796-01; CHEBI:45713; SR-01000000163; Resveratrol, synthetic; SR-01000000163-9; Prestwick2_000508; N88795; 3,5,4'-Trihydroxy-trans-stilbene; resveratrol; 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-; cis-3,5,4'-trihydroxystilbene; AIDS025474; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; SPBio_002356; BPBio1_000479; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Spectrum4_001896; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; EU-0101111; ST057251; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; resveratrol ; KBioSS_000454; 1684AH; Spectrum3_001821; STL; CHEBI:36002; SPBio_001513; IDI1_002152; Prestwick1_000508; 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E; 3,5,4'-Trihydroxystilbene; 3,4',5-trihydroxy stilbene; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; trans-3,4′,5-Trihydroxystilbene; 31100-06-8; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Cis resveratrol; SRT-501; NSC327430; 3,4′,5-Trihydroxy-trans-stilbene; Spectrum_001148; 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00024003-04; Prestwick3_000508; NCGC00015894-02; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00017352-03; SCHEMBL1931746; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; BSPBio_003461; Bio2_000877; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-; 31100-06-8 (DELETED); Z-Resveratrol; UNII-AUA0K06FSB; 501-36-0; C03582; AKOS025395422; KBio2_004196; KBio3_002965; Prestwick0_000508; NSC 327430; 34092_RIEDEL; KBio3_000848; NCGC00017352-02; Spectrum5_000552; MolPort-003-850-143; NCGC00024003-06; KBio2_005590; SpecPlus_000391; AC1LU7HY; AUA0K06FSB; KBioGR_000454; AIDS-025474; BSPBio_000435; cis-resveratrol; KBio2_006764; KBio2_001628; KBioGR_002457; CHEMBL87333; 3,4',5-Trihydroxystilbene; Lopac-R-5010; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; KBio2_000454; Resveratrol, (Z)-; SGCUT00007; CJ-13797; NCGC00024003-07; Resveratrol (Z)-form [MI]; NCGC00017352-01; I14-7425; DivK1c_006487; MolMap_000045; 3,4',5-Stilbenetriol; Oprea1_727238; Tocris-1418; DB-072954; NCGC00017352-04; BSPBio_001114; BDBM50131698; 434C671; LUKBXSAWLPMMSZ-UPHRSURJSA-; KBio3_000847; CAS-501-36-0; SMP1_000257; 4q93; MLS000069735; cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol; ZINC00006787; (Z)-3,5,4'-trihydroxystilbene; to_000079; SPECTRUM1502223; trans-Resveratrol; R5010_SIGMA; KBio2_003022; 61434-67-1; NCGC00024003-02; NCGC00015894-01; CHEBI:27881; Resveratrol; AC-24235; (E)-resveratrol; Prestwick_619; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol; SMR000058206; TNP00294; Resveratrol, Z-; ZINC12353732; Lopac0_001111; cis-3,4',5-trihydroxystilbene; NCI60_002840; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol; Bio2_000397; NCGC00024003-00; (Z)-3,4',5-trihydroxystilbene; 3,5-Dihydroxy-4'-methoxystilbene; 3, 5,4'-trihydroxy-trans-stilbene; cis-3,4,5-Trihydroxystilbene; NCGC00024003-08; RM-1812; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; KBioSS_001628; KBio1_001431; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEBI:45713; Spectrum2_001497; Prestwick2_000508; 3,5,4'-Trihydroxy-trans-stilbene C14H12O3 228.24 g/mol C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
   疾病对应的靶点
靶点ID 基因名 基因别名 描述
TCMBANKGE011859 CFI AHUS3; ARMD13; C3BINA; C3b-INA; FI; IF; KAF complement factor I
TCMBANKGE000914 SMOX C20orf16; PAO; PAO-1; PAO1; PAOH; PAOH1; SMO spermine oxidase
TCMBANKGE013382 ADA - adenosine deaminase
TCMBANKGE000250 CCL5 D17S136E; RANTES; SCYA5; SIS-delta; SISd; TCP228; eoCP C-C motif chemokine ligand 5
TCMBANKGE011217 CD79B AGM6; B29; IGB CD79b molecule
TCMBANKGE000053 NFKB1 CVID12; EBP-1; KBF1; NF-kB; NF-kB1; NF-kappa-B1; NF-kappaB; NF-kappabeta; NFKB-p105; NFKB-p50; NFkappaB nuclear factor kappa B subunit 1
TCMBANKGE000452 CFTR ABC35; ABCC7; CF; CFTR/MRP; MRP7; TNR-CFTR; dJ760C5.1 CF transmembrane conductance regulator
TCMBANKGE009875 PIP GCDFP-15; GCDFP15; GPIP4 prolactin induced protein
TCMBANKGE000660 DNMT3B ICF; ICF1; M.HsaIIIB DNA methyltransferase 3 beta
TCMBANKGE001002 SYT1 BAGOS; P65; SVP65; SYT synaptotagmin 1
TCMBANKGE000752 Il33 9230117N10Rik; Il-33; Il1f11; NF-HEV interleukin 33
TCMBANKGE007843 PSMB9 LMP2; PRAAS3; PSMB6i; RING12; beta1i proteasome 20S subunit beta 9
TCMBANKGE000324 BTK AGMX1; AT; ATK; BPK; IGHD3; IMD1; PSCTK1; XLA Bruton tyrosine kinase
TCMBANKGE000316 IL5 EDF; IL-5; TRF interleukin 5
TCMBANKGE006297 HLA-DPA1 DP(W3); DP(W4); DPA1; HLA-DP1A; HLA-DPB1; HLADP; HLASB; PLT1 major histocompatibility complex, class II, DP alpha 1
TCMBANKGE008946 BLM BS; MGRISCE1; RECQ2; RECQL2; RECQL3 BLM RecQ like helicase
TCMBANKGE000067 NCF1 NCF1A; NOXO2; SH3PXD1A; p47phox neutrophil cytosolic factor 1
TCMBANKGE000135 CXCR4 CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS C-X-C motif chemokine receptor 4
TCMBANKGE000245 CYBB AMCBX2; CGD; GP91-1; GP91-PHOX; GP91PHOX; IMD34; NOX2; p91-PHOX cytochrome b-245 beta chain
TCMBANKGE001074 ATM AT1; ATA; ATC; ATD; ATDC; ATE; TEL1; TELO1 ATM serine/threonine kinase
TCMBANKGE009048 PTPN22 LYP; LYP1; LYP2; PEP; PTPN22.5; PTPN22.6; PTPN8 protein tyrosine phosphatase non-receptor type 22
TCMBANKGE008964 NCF4 CGD3; NCF; P40PHOX; SH3PXD4 neutrophil cytosolic factor 4
TCMBANKGE014769 POSTN OSF-2; OSF2; PDLPOSTN; PN periostin
TCMBANKGE004021 FMR1 FMRP; FRAXA; POF; POF1 FMRP translational regulator 1
TCMBANKGE000568 MET AUTS9; DFNB97; HGFR; RCCP2; c-Met MET proto-oncogene, receptor tyrosine kinase
TCMBANKGE010052 H3P40 p50 H3 histone pseudogene 40
TCMBANKGE010263 WAS IMD2; SCNX; THC; THC1; WASP; WASPA WASP actin nucleation promoting factor
TCMBANKGE000882 SERPINE1 PAI; PAI-1; PAI1; PLANH1 serpin family E member 1
TCMBANKGE008068 PRTN3 ACPA; AGP7; C-ANCA; CANCA; MBN; MBT; NP-4; NP4; P29; PR-3; PR3 proteinase 3
TCMBANKGE013271 IRF8 H-ICSBP; ICSBP; ICSBP1; IMD32A; IMD32B; IRF-8 interferon regulatory factor 8
TCMBANKGE001184 RELA CMCU; NFKB3; p65 RELA proto-oncogene, NF-kB subunit
TCMBANKGE003378 IGLL1 14.1; AGM2; CD179b; IGL1; IGL5; IGLJ14.1; IGLL; IGO; IGVPB; VPREB2 immunoglobulin lambda like polypeptide 1
TCMBANKGE000314 LTC4S - leukotriene C4 synthase
TCMBANKGE009556 NCF2 NCF-2; NOXA2; P67-PHOX; P67PHOX neutrophil cytosolic factor 2
TCMBANKGE000699 CYBA p22-PHOX cytochrome b-245 alpha chain
TCMBANKGE000611 CSF2 CSF; GMCSF colony stimulating factor 2
TCMBANKGE004879 WNK1 HSAN2; HSN2; KDP; PPP1R167; PRKWNK1; PSK; p65 WNK lysine deficient protein kinase 1
TCMBANKGE012549 ARHGEF7 BETA-PIX; COOL-1; COOL1; Nbla10314; P50; P50BP; P85; P85COOL1; P85SPR; PAK3; PIXB Rho guanine nucleotide exchange factor 7
TCMBANKGE000204 CXCL8 GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 C-X-C motif chemokine ligand 8
TCMBANKGE013679 DICER1 DCR1; Dicer; Dicer1e; GLOW; HERNA; K12H4.8-LIKE; MNG1; RMSE2 dicer 1, ribonuclease III
TCMBANKGE000202 RUNX2 AML3; CBF-alpha-1; CBFA1; CCD; CCD1; CLCD; OSF-2; OSF2; PEA2aA; PEBP2aA RUNX family transcription factor 2
TCMBANKGE000563 CLU AAG4; APO-J; APOJ; CLI; CLU1; CLU2; KUB1; NA1/NA2; SGP-2; SGP2; SP-40; TRPM-2; TRPM2 clusterin
TCMBANKGE006564 PSMB4 HN3; HsN3; PRAAS3; PROS-26; PROS26 proteasome 20S subunit beta 4
TCMBANKGE001097 HIF1A HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78 hypoxia inducible factor 1 subunit alpha
TCMBANKGE006160 AZGP1 ZA2G; ZAG alpha-2-glycoprotein 1, zinc-binding
TCMBANKGE014480 CCL7 FIC; MARC; MCP-3; MCP3; NC28; SCYA6; SCYA7 C-C motif chemokine ligand 7
TCMBANKGE002159 PDPN AGGRUS; GP36; GP40; Gp38; HT1A-1; OTS8; PA2.26; T1A; T1A-2; T1A2; TI1A podoplanin
TCMBANKGE012446 IL2RG CD132; CIDX; IL-2RG; IMD4; P64; SCIDX; SCIDX1 interleukin 2 receptor subunit gamma
TCMBANKGE002614 BLNK AGM4; BASH; BLNK-S; LY57; SLP-65; SLP65; bca B cell linker
TCMBANKGE014848 SLC9A6 MRSA; NHE6 solute carrier family 9 member A6
TCMBANKGE008531 ASCC1 ASC1p50; CGI-18; SMABF2; p50 activating signal cointegrator 1 complex subunit 1
TCMBANKGE004878 RFXAP - regulatory factor X associated protein
TCMBANKGE007056 NME8 CILD6; HEL-S-99; NM23-H8; SPTRX2; TXNDC3; sptrx-2 NME/NM23 family member 8
TCMBANKGE010125 ACR - acrosin
TCMBANKGE002000 CTLA4 ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12 cytotoxic T-lymphocyte associated protein 4
TCMBANKGE003272 TCF3 AGM8; E2A; E47; ITF1; TCF-3; VDIR; bHLHb21; p75 transcription factor 3
TCMBANKGE008566 PNP NP; PRO1837; PUNP purine nucleoside phosphorylase
TCMBANKGE006006 RAG2 RAG-2 recombination activating 2
TCMBANKGE000357 MGP GIG36; MGLAP; NTI matrix Gla protein
TCMBANKGE007252 IL22 IL-21; IL-22; IL-D110; IL-TIF; ILTIF; TIFIL-23; TIFa; zcyto18 interleukin 22
TCMBANKGE000908 MUC5AC MUC5; TBM; leB; mucin mucin 5AC, oligomeric mucus/gel-forming
TCMBANKGE000240 IL17A CTLA-8; CTLA8; IL-17; IL-17A; IL17 interleukin 17A
TCMBANKGE002491 SLC5A5 NIS; TDH1 solute carrier family 5 member 5
TCMBANKGE001189 IL1A IL-1 alpha; IL-1A; IL1; IL1-ALPHA; IL1F1 interleukin 1 alpha
TCMBANKGE002767 WIPF1 PRPL-2; WAS2; WASPIP; WIP WAS/WASL interacting protein family member 1
TCMBANKGE006405 CCL11 SCYA11 C-C motif chemokine ligand 11
TCMBANKGE006611 ST8SIA4 PST; PST1; SIAT8D; ST8SIA-IV ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
TCMBANKGE004555 CD79A IGA; MB-1 CD79a molecule
TCMBANKGE006122 GORASP1 GOLPH5; GRASP65; P65 golgi reassembly stacking protein 1
TCMBANKGE000046 PIK3R1 AGM7; GRB1; IMD36; p85; p85-ALPHA phosphoinositide-3-kinase regulatory subunit 1
TCMBANKGE000933 IKBKB IKK-beta; IKK2; IKKB; IMD15; IMD15A; IMD15B; NFKBIKB inhibitor of nuclear factor kappa B kinase subunit beta
TCMBANKGE011220 CIITA C2TA; CIITAIV; MHC2TA; NLRA class II major histocompatibility complex transactivator
TCMBANKGE004382 DNAAF1 CILD13; DAU1; LRRC50; ODA7; swt dynein axonemal assembly factor 1
TCMBANKGE009438 PTGDS L-PGDS; LPGDS; PDS; PGD2; PGDS; PGDS2 prostaglandin D2 synthase
TCMBANKGE007239 RFXANK ANKRA1; BLS; F14150_1; RFX-B regulatory factor X associated ankyrin containing protein
TCMBANKGE003651 MUC5B MG1; MUC-5B; MUC5; MUC9 mucin 5B, oligomeric mucus/gel-forming
TCMBANKGE000008 CD40 Bp50; CDW40; TNFRSF5; p50 CD40 molecule
TCMBANKGE007530 HLA-DPB1 DPB1; HLA-DP; HLA-DP1B; HLA-DPB major histocompatibility complex, class II, DP beta 1
TCMBANKGE000349 NBN AT-V1; AT-V2; ATV; NBS; NBS1; P95 nibrin
TCMBANKGE001029 IL13 IL-13; P600 interleukin 13
TCMBANKGE014087 EPX EPO; EPP; EPX-PEN; EPXD eosinophil peroxidase
TCMBANKGE012037 LRRC8A AGM5; LRRC8; SWELL1 leucine rich repeat containing 8 VRAC subunit A

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇IICP备16009434号-1 | Dai SX Lab